Comparative analysis of collagen type II-specific immune responses during development of collagen-induced arthritis in two B10 mouse strains

Arthritis Research and Therapy

Volumn 14, Issue 6, 2012, Pages

  Batsalova, Tsvetelina ^a   Lindh, Ingrid ^a   Bäcklund, Johan ^a   Dzhambazov, Balik ^a   Holmdahl, Rikard ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2; EPITOPE; GAMMA INTERFERON; HLA DR4 ANTIGEN; HLA DRB1 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; C57BL 10 MOUSE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOSYLATION; HUMORAL IMMUNITY; IMMUNE RESPONSE; MALE; MOUSE; NONHUMAN; PROTEIN PROCESSING; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; ANIMAL; ANTIBODY PRODUCTION; EXPERIMENTAL ARTHRITIS; HUMAN; IMMUNOLOGY; METABOLISM; SPECIES DIFFERENCE; TIME; TRANSGENIC MOUSE;

ANIMALS; ANTIBODY FORMATION; ANTIBODY SPECIFICITY; ARTHRITIS, EXPERIMENTAL; COLLAGEN TYPE II; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES, T-LYMPHOCYTE; FEMALE; HUMANS; INTERFERON-GAMMA; MALE; MICE, TRANSGENIC; SPECIES SPECIFICITY; T-LYMPHOCYTES; TIME FACTORS;

EID: 84868235953     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4080     Document Type: Article

References (31)

1. Brand DD, Kang AH, Rosloniec EF. Immunopathogenesis of collagen arthritis. Springer Semin Immunopathol 2003, 25:3-18. 10.1007/s00281-003-0127-1, 12904888.
2. Rosloniec EF, Brand DD, Myers LK, Esaki Y, Whittington KB, Zaller DM, Woods A, Stuart JM, Kang AH. Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen. J Immunol 1998, 160:2573-2578.
3. Rosloniec EF, Brand DD, Myers LK, Whittington KB, Gumanovskaya M, Zaller DM, Woods A, Altmann DM, Stuart JM, Kang AH. An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen. J Exp Med 1997, 185:1113-1122. 10.1084/jem.185.6.1113, 2196244, 9091584.
4. Andersson EC, Hansen BE, Jacobsen H, Madsen LS, Andersen CB, Engberg J, Rothbard JB, McDevitt GS, Malmstrom V, Holmdahl R, Svejgaard A, Fugger L. Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice. Proc Natl Acad Sci USA 1998, 95:7574-7579. 10.1073/pnas.95.13.7574, 22687, 9636191.
5. Backlund J, Carlsen S, Hoger T, Holm B, Fugger L, Kihlberg J, Burkhardt H, Holmdahl R. Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis. Proc Natl Acad Sci USA 2002, 99:9960-9965. 10.1073/pnas.132254199, 126607, 12089323.
6. Snir O, Backlund J, Bostrom J, Andersson I, Kihlberg J, Buckner JH, Klareskog L, Holmdahl R, Malmstrom V. Multifunctional T cell reactivity to native and glycosylated type-II collagen in rheumatoid arthritis. Arthritis Rheum 2012, (64):2482-8.
7. Kim WU, Kim KJ. T cell proliferative response to type II collagen in the inflammatory process and joint damage in patients with rheumatoid arthritis. J Rheumatol 2005, 32:225-230.
8. Kim WU, Yoo WH, Park W, Kang YM, Kim SI, Park JH, Lee SS, Joo YS, Min JK, Hong YS, Lee SH, Park SH, Cho CS, Kim HY. IgG antibodies to type II collagen reflect inflammatory activity in patients with rheumatoid arthritis. J Rheumatol 2000, 27:575-581.
9. Cook AD, Rowley MJ, Mackay IR, Gough A, Emery P. Antibodies to type II collagen in early rheumatoid arthritis. Correlation with disease progression. Arthritis Rheum 1996, 39:1720-1727. 10.1002/art.1780391015, 8843863.
10. Michaelsson E, Andersson M, Engstrom A, Holmdahl R. Identification of an immunodominant type-II collagen peptide recognized by T cells in H-2q mice: self tolerance at the level of determinant selection. Eur J Immunol 1992, 22:1819-1825. 10.1002/eji.1830220722, 1378019.
11. Fugger L, Rothbard JB, Sonderstrup-McDevitt G. Specificity of an HLA-DRB1*0401-restricted T cell response to type II collagen. Eur J Immunol 1996, 26:928-933. 10.1002/eji.1830260431, 8625990.
12. Diab BY, Lambert NC, L'Faqihi FE, Loubet-Lescoulie P, de Preval C, Coppin H. Human collagen II peptide 256-271 preferentially binds to HLA-DR molecules associated with susceptibility to rheumatoid arthritis. Immunogenetics 1999, 49:36-44. 10.1007/s002510050461, 9811967.
13. Kim HY, Kim WU, Cho ML, Lee SK, Youn J, Kim SI, Yoo WH, Park JH, Min JK, Lee SH, Park SH, Cho CS. Enhanced T cell proliferative response to type II collagen and synthetic peptide CII (255-274) in patients with rheumatoid arthritis. Arthritis Rheum 1999, 42:2085-2093. 10.1002/1529-0131(199910)42:10<2085::AID-ANR8>3.0.CO;2-Z, 10524679.
14. Burkhardt H, Koller T, Engstrom A, Nandakumar KS, Turnay J, Kraetsch HG, Kalden JR, Holmdahl R. Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse. Arthritis Rheum 2002, 46:2339-2348. 10.1002/art.10472, 12355481.
15. Schulte S, Unger C, Mo JA, Wendler O, Bauer E, Frischholz S, von der Mark K, Kalden JR, Holmdahl R, Burkhardt H. Arthritis-related B cell epitopes in collagen II are conformation-dependent and sterically privileged in accessible sites of cartilage collagen fibrils. J Biol Chem 1998, 273:1551-1561. 10.1074/jbc.273.3.1551, 9430695.
16. Kraetsch HG, Unger C, Wernhoff P, Schneider C, Kalden JR, Holmdahl R, Burkhardt H. Cartilage-specific autoimmunity in rheumatoid arthritis: characterization of a triple helical B cell epitope in the integrin-binding-domain of collagen type II. Eur J Immunol 2001, 31:1666-1673. 10.1002/1521-4141(200106)31:6<1666::AID-IMMU1666>3.0.CO;2-T, 11385610.
17. Bajtner E, Nandakumar KS, Engstrom A, Holmdahl R. Chronic development of collagen-induced arthritis is associated with arthritogenic antibodies against specific epitopes on type II collagen. Arthritis Res Ther 2005, 7:R1148-1157. 10.1186/ar1800, 1257444, 16207332.
18. Nandakumar KS, Holmdahl R. Efficient promotion of collagen antibody induced arthritis (CAIA) using four monoclonal antibodies specific for the major epitopes recognized in both collagen induced arthritis and rheumatoid arthritis. J Immunol Methods 2005, 304:126-136. 10.1016/j.jim.2005.06.017, 16125192.
19. Andersson M, Holmdahl R. Analysis of type II collagen-reactive T cells in the mouse. I. Different regulation of autoreactive vs. non-autoreactive anti-type II collagen T cells in the DBA/1 mouse. Eur J Immunol 1990, 20:1061-1066. 10.1002/eji.1830200517, 1694131.
20. Fugger L, Michie SA, Rulifson I, Lock CB, McDevitt GS. Expression of HLA-DR4 and human CD4 transgenes in mice determines the variable region beta-chain T-cell repertoire and mediates an HLA-DR-restricted immune response. Proc Natl Acad Sci USA 1994, 91:6151-6155. 10.1073/pnas.91.13.6151, 44156, 8016129.
21. Hultqvist M, Olofsson P, Holmberg J, Backstrom BT, Tordsson J, Holmdahl R. Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc Natl Acad Sci USA 2004, 101:12646-12651. 10.1073/pnas.0403831101, 515111, 15310853.
22. Holmdahl R, Carlsen S, Mikuloowska A, Vestberg M, Brunsberg U, Hansson A, Sundvall M, Jansson L, Pettersson U. Genetic analysis of mouse models for rheumatoid arthritis. Human Genome Methods 1998, 215-238. New York: CRC Press.
23. Batsalova T, Dzhambazov B, Merky P, Backlund A, Backlund J. Breaking T cell tolerance against self type II collagen in HLA-DR4-transgenic mice and development of autoimmune arthritis. Arthritis Rheum 62:1911-1920.
24. Corthay A, Backlund J, Broddefalk J, Michaelsson E, Goldschmidt TJ, Kihlberg J, Holmdahl R. Epitope glycosylation plays a critical role for T cell recognition of type II collagen in collagen-induced arthritis. Eur J Immunol 1998, 28:2580-2590. 10.1002/(SICI)1521-4141(199808)28:08<2580::AID-IMMU2580>3.0.CO;2-X, 9710235.
25. Ito Y, Usui T, Kobayashi S, Iguchi-Hashimoto M, Ito H, Yoshitomi H, Nakamura T, Shimizu M, Kawabata D, Yukawa N, Hashimoto M, Sakaguchi N, Sakaguchi S, Yoshifuji H, Nojima T, Ohmura K, Fujii T, Mimori T. Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis. Arthritis Rheum 2009, 60:2294-2303. 10.1002/art.24687, 19644886.
26. Rosloniec EF, Latham K, Guedez YB. Paradoxical roles of IFN-gamma in models of Th1-mediated autoimmunity. Arthritis Res 2002, 4:333-336. 10.1186/ar432, 153838, 12453308.
27. Backlund J, Treschow A, Bockermann R, Holm B, Holm L, Issazadeh-Navikas S, Kihlberg J, Holmdahl R. Glycosylation of type II collagen is of major importance for T cell tolerance and pathology in collagen-induced arthritis. Eur J Immunol 2002, 32:3776-3784. 10.1002/1521-4141(200212)32:12<3776::AID-IMMU3776>3.0.CO;2-A, 12516572.
28. Dzhambazov B, Holmdahl M, Yamada H, Lu S, Vestberg M, Holm B, Johnell O, Kihlberg J, Holmdahl R. The major T cell epitope on type II collagen is glycosylated in normal cartilage but modified by arthritis in both rats and humans. Eur J Immunol 2005, 35:357-366. 10.1002/eji.200425637, 15682451.
29. Terato K, Hasty KA, Reife RA, Cremer MA, Kang AH, Stuart JM. Induction of arthritis with monoclonal antibodies to collagen. J Immunol 1992, 148:2103-2108.
30. Holmdahl R, Jansson L, Gullberg D, Rubin K, Forsberg PO, Klareskog L. Incidence of arthritis and autoreactivity of anti-collagen antibodies after immunization of DBA/1 mice with heterologous and autologous collagen II. Clin Exp Immunol 1985, 62:639-646. 1577464, 4085150.
31. Nandakumar KS, Bajtner E, Hill L, Bohm B, Rowley MJ, Burkhardt H, Holmdahl R. Arthritogenic antibodies specific for a major type II collagen triple-helical epitope bind and destabilize cartilage independent of inflammation. Arthritis Rheum 2008, 58:184-196. 10.1002/art.23049, 18163493.